Causes and consequences of lymphatic disease

被引:33
作者
Rockson, Stanley G. [1 ]
机构
[1] Stanford Univ, Sch Med, Ctr Lymphat & Venous Disorders, Falk Cardiovasc Res Ctr,Div Cardiovasc Med, Stanford, CA 94305 USA
来源
LYMPHATICS IN THE DIGESTIVE SYSTEM: PHYSIOLOGY, HEALTH, AND DISEASE | 2010年 / 1207卷
关键词
lymphedema; lymphangiectasia; lymphangiomatosis; chylous effusion; protein-losing enteropathy; bioimpedance spectroscopy; Prox-1; PROTEIN-LOSING ENTEROPATHY; CHRONIC ARM LYMPHEDEMA; VEGF-C; SECONDARY LYMPHEDEMA; THERAPEUTIC LYMPHANGIOGENESIS; BREAST-CANCER; INTERSTITIAL FLOW; GENE-THERAPY; PROX1; MODEL;
D O I
10.1111/j.1749-6632.2010.05804.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The visceral manifestations of lymphatic disorders (lymphangiomatosis and lymphangiectasia) are particularly severe. Any pathology of the lymphatic vasculature, whether superficial or internal, regional, or systemic, is predominated by the appearance of lymphedema, the characteristic form of tissue edema that occurs when lymphatic dysfunction supervenes. Disease manifestationsmay include dysregulation of body fluid homeostasis, immune traffic impairment, and disturbances of lipid and protein reabsorption from the gut lumen. The appearance of lymphatic edema invokes complex biological alterations. Many of these changes seem to relate uniquely to chronic lymphatic edema, including a profound stimulus to collagen and adipose deposition. Despite the recent advances in our understanding of these disorders, substantial knowledge gaps remain; these gaps inhibit our ability to accurately identify, categorize, treat, and prevent these diseases. Future diagnostic, therapeutic, and reproductive decisions for affected individuals require an accurate knowledge of the clinical and laboratory presentation, mode of inheritance, treatment response, outcomes, and prognosis.
引用
收藏
页码:E2 / E6
页数:5
相关论文
共 48 条
[1]  
Beilhack Andreas, 2003, Lymphat Res Biol, V1, P219, DOI 10.1089/153968503768330256
[2]   Interstitial flow as a guide for lymphangiogenesis [J].
Boardman, KC ;
Swartz, MA .
CIRCULATION RESEARCH, 2003, 92 (07) :801-808
[3]  
Brorson H, 2003, Scand J Surg, V92, P287
[4]  
Brorson Hakan, 2006, Lymphatic Research and Biology, V4, P199, DOI 10.1089/lrb.2006.4404
[5]  
Brorson Hakan, 2009, Lymphatic Research and Biology, V7, P3, DOI 10.1089/lrb.2008.1022
[6]   An experimental model for the study of lymphedema and its response to therapeutic lymphangiogenesis [J].
Cheung, Lauren ;
Han, Jennifer ;
Beilhack, Andreas ;
Joshi, Smita ;
Wilburn, Paul ;
Dua, Aman ;
An, Andrew ;
Rockson, Stanley G. .
BIODRUGS, 2006, 20 (06) :363-370
[7]  
Cornish Bruce, 2006, Lymphatic Research and Biology, V4, P47, DOI 10.1089/lrb.2006.4.47
[8]  
Ferrell Robert E., 2008, Lymphatic Research and Biology, V6, P69, DOI 10.1089/lrb.2007.1022
[9]  
Fife CE, 2008, OSTOMY WOUND MANAG, V54, P44
[10]  
Finegold David N., 2008, Lymphatic Research and Biology, V6, P65, DOI 10.1089/lrb.2008.1524